95268 ⎘
Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links
ELECTRONIC DEVICE
#3024-phenyl-coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer
#303Methods, systems, and apparatus for the monitoring, controlling, and communicating of electronic devices
#304Heterocyclylsulfonyl-substituted pyridines and their use in the treatment of cancer
#305A PROCESS FOR THE PREPARATION OF D-GLUCITOL, 1,5-ANHYDRO-1-C-[4-CHLORO-3-[[4- [[(3S)-TETRAHYDRO-3-FURANYL]OXY]PHENYL]METHYL]PHENYL]-, ( 1 S)
#306MATERIALS FOR ELECTRONIC DEVICES
#307Substituted esters containing polyols and saccharides for treating hepatotoxicity and fatty liver diseases
#308FUNGICIDAL PYRAZOLES
#309Sulfoximine glycosidase inhibitors
#310Griseofulvin compound
#311Phenanthrene compounds for organic electronic devices
#312PROCESS FOR PRODUCING 5-(ALKOXYCARBONYL)FURAN-2-CARBOXYLIC ACIDS AND COMPOSITIONS CONTAINING SAME
#313Substituted dihydrobenzofuran glycosidase inhibitors
#314Heterocyclic urea compound, and drug composition and application thereof
#315N-{[2-(piperidin-1-yl)phenyl](phenyl)methyl}-2-(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl)acetamide derivatives and related compounds as ROR-gamma modulators for treating autoimmune diseases
#316Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof
#317Sulfonylureas and related compounds and use of same
#318Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof
#319Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof
#320Therapeutic compounds and compositions
#321Method for manufacturing 1,3-dioxane-5-one
#322Plant growth regulator compounds
#323Method for producing glyceric acid ester
#324METHODS FOR SYNTHESIZING HIGH PURITY EPOXY COMPOUNDS AND PRODUCTS OBTAINED THEREFROM
#325Anticancer agent
#326Cyclopropanamine compound and use thereof
#327Apelin receptor (APJ) agonists and uses thereof
#328Inhibitors of tryptophan 2,3-dioxygenase
#329Small molecule ferroptosis inducers
#330Aromatic amine derivatives, preparation methods therefor, and uses thereof
#331Benzo-N-hydroxy amide compounds having antitumor activity
#332Methods and apparatus for synthesizing imaging agents, and intermediates thereof
#333Cyclic peroxides as prodrugs for selective delivery of agents
#334Anticancer compounds
#335Substituted oxepines
#336Process for preparation of eribulin and intermediates thereof
#337Modulators of cystic fibrosis transmembrane conductance regulator
#338Glucosylceramide synthase inhibitors for the treatment of diseases
#339Purification of oxydiphthalic anhydrides
#340Compositions and methods for inhibition of the JAK pathway
#341Compound, resist composition and method for producing resist pattern
#342Epoxy resin
#343Benzyl phenyl ether derivative, preparation method therefor, and pharmaceutical composition and uses thereof
#344Hsp70 modulators and methods for making and using the same
#345THERAPEUTIC COMPOUNDS AND COMPOSITIONS
#346Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
#347ORGANIC ELECTROLUMINESCENCE DEVICE AND MONOAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE
#348Organic electroluminescence device and monoamine compound for organic electroluminescence device
#349Phenylate derivative, preparation method therefor, and pharmaceutical composition and uses thereof
#350Compositions and methods for neuraminidase detection and quantification
#351Chemokine CXCR1 and CXCR2 receptor antagonist compounds, and use thereof in the treatment of chemokine-mediated pathologies
#352Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same
#353ANTI-INFECTIVE AGENTS
#354Azadecalin derivatives as inhibitors of human immunodeficiency virus replication
#355Process for preparing spiroketal-substituted cyclic ketoenols
#356COALESCING AGENT DERIVED FROM DIOXOLANE DERIVATIVES
#3572,4-disubstituted pyrimidines useful as kinase inhibitors
#358Quinazolines as potassium ion channel inhibitors
#359Polyfunctional oxetane-based compound and production method thereof
#360Substituted Tricyclics and Method of Use
#361Small molecules active against gram-negative bacteria
#362Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
#363Substituted Chromanes and Method of Use
#364Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents
#365Substituted 2,4-diaminopyrimidines as kinase inhibitors
#366TAF1 inhibitors for the therapy of cancer
#367BICYCLIC COMPOUND AND USE THEREOF FOR MEDICAL PURPOSES
#368Fused 1,4-dihydrodioxin derivatives as inhibitors of heat shock transcription factor I
#369Processes for the preparation of cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9H-purin-9-yl]-1-methylcyclohexane-1-carboxamide
#370HETEROCYCLIC SULFONAMIDES, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF
#371Medicament for liver regeneration and for treatment of liver failure
#372SODIUM GLUCOSE CO-TRANSPORTER INHIBITORS AND METHODS OF THEIR USE
#373Griseofulvin compound
#374MEDICAMENT FOR LIVER REGENERATION AND FOR TREATMENT OF LIVER FAILURE
#375Amide-sulfamide derivatives, compositions, and uses related to CXCR4 inhibition
#376Strigolactone formulations and uses thereof
#377Compounds
#378TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS
#379Fungicidal pyrazoles
#380Methods for 1,4-diazo n-heterocycle synthesis
#381Processes for producing beta-lactone and beta-lactone derivatives with heterogenous catalysts
#382BICYCLIC COMPOUND, PRODUCTION AND USE THEREOF
#383REDUNDANT POWER LINE CONTROL SYSTEMS
#384Controlling zones of electronic devices associated with power lines
#385Methods and systems for wireless to power line communication
#386MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES
#387Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof
#388VITAMIN D RECEPTOR-COREGULATOR INHIBITORS
#389Compound for organic electric device, organic electric device using same, and electronic device
#390Heterocyclic compound and organic light emitting diode containing same
#391Small molecule agonists and antagonists of NR2F6 activity in animals
#392Lactone-based probes and methods of use thereof
#393Pyridine derivative
#394Tricyclic spiro compound
#395Polymorphic forms of Afatinib free base and Afatinib dimaleate
#396Methods for hydraulic enhancement of crops
#397PPAR agonists and methods of use thereof
#398COMPOUNDS, COMPOSITIONS AND METHODS OF USE AGAINST STRESS GRANULES
#399Systems and processes for thermolysis of polylactones to produce organic acids
#400Compounds useful as modulators of TRPM8
#401Compound and organic light emitting diode comprising same
#4024-substituted coumarin derivatives and preparation methods and uses thereof
#403Coumarin-linked taxanes for detection and circumvention of cellular efflux
#404Apelin receptor (APJ) agonists and uses thereof
#405Anticancer agent
#406Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device
#407Substituted esters containing polyols and saccharides for treating hepatotoxicity and fatty liver diseases
#408Processes and intermediates for the preparations of isomer free prostaglandins
#409Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
#410Cathepsin K inhibitors and application thereof
#411Fluorene derivative, method for producing the same, resin composition, and article
#412Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
#413Oxime ester photoinitiators
#414Phenoxymethyl derivatives
#415SPIROCYCLIC HAT INHIBITORS AND METHODS FOR THEIR USE
#416N-(tetrazol-5-yl)- and N-(triazol-5-yl)arylcarboxamide derivatives with herbicidal action
#417Modulators of cystic fibrosis transmembrane conductance regulator
#418N-sulfonyl homoserine lactone derivatives, preparation method and use thereof
#419Hsp70 modulators and methods for making and using the same
#420PPAR agonists
#421HYDROXYLATED AND METHOXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS
#422Cyclopropanamine compound and use thereof
#423Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents
#424Heterocyclic compound and organic electroluminescence device including the same
#425Morphinan derivatives for the treatment of neuropathic pain
#426Compound for organic electric element, organic electric element comprising the same and electronic device thereof
#427Process for preparing 4-amino-5-biphenyl-4-yl-2-hydroxymethyl-2-methyl-pentanoic acid compound
#428Bicyclic compound and use thereof for medical purposes
#429Phenanthrene compounds for organic electronic devices
#430Inhibitors of histone deacetylase
#431Compounds as rearranged during transfection (RET) inhibitors
#432Compounds and organic electronic devices
#4332-Acylaminopropoanol-Type Glucosylceramide Synthase Inhibitors
#434Compositions of protein receptor tyrosine kinase inhibitors
#435Heterocyclic modulators of lipid synthesis
#436Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer
#437Compound for organic electric element, organic electric element comprising the same and electronic device thereof
#438Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer
#439SPIROCYCLIC HAT INHIBITORS AND METHODS FOR THEIR USE
#440Compositions and methods for treating respiratory injury or disease
#441Processes and intermediates for the preparations of isomer free prostaglandins
#442Sulfonylureas and related compounds and use of same
#443Substituted Tricyclics and Method of Use
#444Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
#445Quinazolines as potassium ion channel inhibitors
#446Substituted benzofuran compounds for the treatment of hepatitis C
#447Spirobifluorene derivative-based materials for electronic devices
#448Liquid crystal compound having benzopyran skeleton, liquid crystal composition, and liquid crystal display device
#449Compounds for stabilizing ryanodine receptors from aberrant levels of calcium release
#450GLP-1 receptor modulators
#451Autotaxin inhibitors
#452INHIBITORS OF HISTONE DEACETYLASE
#453Tricyclic spiro compound
#454Polymerizable compound and optically anisotropic object
#455METHODS FOR THE STEREOSELECTIVE PREPARATION OF APIOSE DERIVATIVES FROM ALLYLIC ALCOHOL COMPOUNDS AND ALLENE COMPOUNDS USING CATALYTIC ASYMMETRIC SYNTHESIS
#456Compounds, compositions, and methods for increasing CFTR activity
#457Modulation of Bacterial Quorum Sensing with Synthetic Ligands
#458Treatment or prophylaxis of proliferative conditions
#459Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
#460Chemokine CXCR1 and CXCR2 receptor antagonist compounds, and use thereof in the treatment of chemokine-mediated pathologies
#461Silvestrol antibody-drug conjugates and methods of use
#462Flash and Glow 1,2-Dioxetanes
#463Amorphous Empagliflozin
#464Modulators of cystic fibrosis transmembrane conductance regulator protein
#465Heterocyclic compounds with benzo(c)coumarin-structures
#466Bicyclic compound and pharmaceutical composition thereof for treating stroke and use thereof
#467Methods and apparatus for synthesizing imaging agents, and intermediates thereof
#468HETEROCYCLIC SULFONAMIDES, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF
#469Process for preparing SGLT2 inhibitors and intermediates thereof
#470HSP70 modulators and methods for making and using the same
#471IDO inhibitors
#472Noxious arthropod control agent containing amide compound
#473Apigenin analogs, compositions, and methods related thereto
#474SUBSTITUTED CHROMANES AND METHOD OF USE
#475Compound and liquid-crystal composition employing the same
#476Vitamin D receptor-coregulator inhibitors
#477Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
#478Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
#479Substituted chroman-6-yloxy-cycloalkanes and their use as pharmaceuticals
#480Methods of treatment using selective 5-HT2A inverse agonists
#481Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
#482Compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing the same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient
#483Scaphopetalone analogs and their uses
#484Compounds for selective histone deacetylase inhibitors, and pharmaceutical composition comprising the same
#485Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
#486Materials for organic electroluminescent devices
#487Anticancer agent
#488C-glycoside derivative
#489Purification of taxanes
#490Condensed-cyclic compound and organic light emitting device comprising the same
#491Phenyl c-glucoside derivative containing deoxyglucose structure, preparation method and use thereof
#492Compounds for treating viral infections
#493C-aryl glycosid derivatives, pharmaceutical composition, preparation process and uses thereof
#494Fused 1,4-dihydrodioxin derivatives as inhibitors of heat shock transcription factor I
#495Cyclopropanamine compound and use thereof
#496Tetrahydro-benzoimidazolyl modulators of TGR5
#497Benzamides
#498Amido-substituted azole compounds
#499Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors
#500Substituted tricyclics and method of use
#501Processes and intermediates for the preparations of isomer free prostaglandis
#502SUBSTITUTED PYRAN DERIVATIVES
#503Cyclopropanamine compound and use thereof
#504Cyclic peroxides as prodrugs for selective delivery of agents
#505Quinazolines as potassium ion channel inhibitors
#506Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents
#507Inhibitors of histone deacetylase
#5082-acylaminopropoanol-type glucosylceramide synthase inhibitors
#509TOFA analogs useful in treating dermatological disorders or conditions
#510Heterocyclic sulfonamide derivative and medicine comprising same
#511Process for the preparation of empagliflozin
#512Oxime-substituted amide compound and pest control agent
#513Compounds useful as modulators of TRPM8
#514Cyclopropanamine compound and use thereof
#515Cyclopropanamine compound and use thereof
#516NOVEL TRICYCLIC CALCIUM SENSING RECEPTOR ANTOGONISTS FOR THE TREATMENT OF OSTEOPOSOSIS
#517Compositions and methods for treating respiratory injury or disease
#518Substituted oxepines
#519Substituted 2,4-diaminopyrimidines as kinase inhibitors
#520Anti-cancer agents and preparation thereof
#521Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases
#522Pyrrolidinones as herbicides
#523Fused 1,4-dihydrodioxin derivatives as inhibitors of heat shock transcription factor 1
#524IDO inhibitors
#525Bicyclic compound and use thereof for medical purposes
#526Sulfated and unsulfated flavonoid oligomers as cancer therapeutics
#527Plasticizers for polymers
#528Antibacterial agents: aryl myxopyronin derivatives
#529Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
#530Inhibitors of human immunodeficiency virus replication
#531Dental composition
#532Inhibitors of histone deacetylase
#533Condensed cyclic compound and organic light-emitting device including the same
#534Indenotriphenylene-based amine derivative for organic electroluminescent device
#535Indanyloxydihydrobenzofuranylacetic acids
#536Epoxy compound having alkoxysilyl group, method of preparing the same, composition and cured product comprising the same, and uses thereof
#537Glucosylceramide synthase inhibitors for the treatment of diseases
#538GLP-1 receptor modulators
#5391,2- bis-sulfonamide derivatives as chemokine receptor modulators
#540Synthesis of novel asymmetric bow-tie PAMAM dendrimer-based conjugates for tumor-targeting drug delivery
#541FUNGICIDAL COMPOSITIONS
#542Oxime ester photoinitiators
#543Apelin receptor (APJ) agonists and uses thereof
#544IDO inhibitors
#54515-oxospiramilactone derivatives, preparation method and uses thereof
#546Autotaxin inhibitors
#547Aromatic amine compound, organic electroluminescent element and electronic device
#548N-cyanomethylamides as inhibitors of janus kinase
#549Purification of taxanes
#550Strigolactone formulations and uses thereof
#551Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
#552Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
#553Polymerizable compound, polymerizable composition and liquid crystal display device
#554HYDROXYLATED AND METHOXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS
#555PRMT5 inhibitors and uses thereof
#556Substituted tetrahydropyrans and method of use
#557Substituted chromanes and method of use
#558Condensed cyclic compound and organic light-emitting device including the same
#559ROSEOBACTICIDES AND USES THEREOF
#560POLYCYCLIC HERG ACTIVATORS
#561Condensed cyclic compound and organic light-emitting device including the same
#562Compounds for selective histone deacetylase inhibitors, and pharmaceutical composition comprising the same
#563Process for preparation of dronedarone by removal of hydroxyl group
#564Liquid crystal compound having xanthene skeleton and exhibiting negative dielectric anisotropy, liquid crystal composition and liquid crystal display device
#565Inhibitors of α-amino-β-carboxymuconic acid semialdehyde decarboxylase
#566N-myristoyl transferase inhibitors
#567Casein kinase 1delta (CK1delta) inhibitors
#568Nitroso compounds as nitroxyl donors and methods of use thereof
#569Phenyl C-glucoside derivative containing deoxyglucose structure, preparation method and use thereof
#570PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DIABETES
#571Serotonin receptor modulators
#572NAMPT and ROCK inhibitors
#573Furanyl-imine and thiofuranyl-imine compounds for stabilizing ryanodine receptors from aberrant levels of calcium release
#574Intermediates to prepare herbicidal pyrimidone derivatives
#575PPAR agonists
#576Medicament for liver regeneration and for treatment of liver failure
#577Substituted chroman-6-yloxy-cycloalkanes and their use as pharmaceuticals
#578Processes and intermediates for the preparations of isomer free prostaglandins
#579Tricyclic compound and use thereof
#580Bicyclic compound, production and use thereof
#5811,3-dioxane compound having fluorine atom in axial position, liquid crystal composition and liquid crystal display device
#582Glycomimetics as lectin inhibitors
#583PRMT5 inhibitors and uses thereof
#584Processes and intermediates for the preparations of isomer free prostaglandins
#585Processes and intermediates for the preparations of isomer free prostaglandins
#586Compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing the same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient
#587Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
#588Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
#589Enzyme inhibitors
#590Monomer, polymer, resist composition, and patterning process
#591Compounds that inhibit human DNA ligases and methods of treating cancer
#592Polycyclic HERG activators
#593Dihydropyrone compounds and herbicides comprising the same
#594Tetrazolinone compound and applications thereof
#595Modulators of the retinoid-related orphan receptor gamma (ROR-gamma) for use in the treatment of autoimmune and inflammatory diseases
#596Inhibitors of syk and JAK protein kinases
#597Cyclopropanamine compound and use thereof
#598Octahydro binaphthyl-based chiral compound-containing liquid-crystal composition and optical element
#599Process for preparing 4-amino-5-biphenyl-4-yl-2-hydroxymethyl-2-methyl-pentanoic acid compound
#600Pyrone compounds and herbicides comprising the same